Episode 24: Overview of the Latest Guidance in IgA Nephropathy Management
Update: 2025-10-02
Description
Join Dana Rizk, MD (University of Alabama at Birmingham, United States), and Brad Rovin, MD (Ohio State University, United States), Co-Chair of the 2025 KDIGO IgAN/IgAV Guideline, for a deep dive into the latest updates in patient care. Their conversation explores the most important takeaways from the new guideline, the critical role of kidney biopsies in diagnosis and prognosis, the use of the IgAN prediction tool for risk assessment, and the updated thresholds and treatment goals designed to improve outcomes.
This podcast was supported by Travere.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
